Invention Grant
- Patent Title: Prolyl hydroxylase inhibitors and methods of use
- Patent Title (中): 脯氨酰羟化酶抑制剂及其使用方法
-
Application No.: US13681876Application Date: 2012-11-20
-
Publication No.: US08598210B2Publication Date: 2013-12-03
- Inventor: Richard Masaru Kawamoto , Shengde Wu , Namal C. Warshakoon , Artem G. Evdokimov , Kenneth D. Greis , Angelique Sun Boyer
- Applicant: Akebia Therapeutics Inc.
- Applicant Address: US OH Cincinnati
- Assignee: Akebia Therapeutics, Inc.
- Current Assignee: Akebia Therapeutics, Inc.
- Current Assignee Address: US OH Cincinnati
- Agency: Jones Day
- Main IPC: A01N43/40
- IPC: A01N43/40 ; A61K31/44 ; C07D213/62 ; C07D213/78 ; C07D405/00
Abstract:
The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
Public/Granted literature
- US20130203816A1 PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE Public/Granted day:2013-08-08
Information query
IPC分类:
